Our data exhibited NLRP3 activation after DSS-induced colitis; however, ECE pretreatment reduced NLRP3 expression and further suppressed NF-κB activation, a prerequisite for NLRP3 activation (Figure 5). The gene discussed is NFKB1; the disease is colitis.